BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4976852)

  • 1. [Studies on the lipid metabolism of fetal erythroblastosis Rh and ABO. Non-esterified plasma fatty acids and gas chromatographic fractionation of plasma and erythrocyte fatty acids].
    Salvioli GP; Ambrosioni G; Allocca G
    Haematologica; 1968; 53(7):534-55. PubMed ID: 4976852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thin-layer chromatography of total lipids in hemolytic disease of the newborn (Rh and ABO). 3. Principal lipid fractions in the erythrocyte in toto in the erythrocytic stroma].
    Salvioli GP; Ambrosioni G; Allocca G
    Clin Pediatr (Bologna); 1968 Dec; 50(12):926-31. PubMed ID: 4979138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
    Ambrosioni G; Serritelli G
    Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical changes in erythrocytes in iso- and auto-immune hemolytic anemias].
    Kovalev IuR
    Vopr Med Khim; 1970; 16(5):477-82. PubMed ID: 5002345
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatty acid composition of phospholipids in erythrocytes of adults, normal newborn infants, and neonates with Rh erythroblastosis.
    Gercken G; Tiling T; Brockmann U; Schröter W
    Pediatr Res; 1972 May; 6(5):487-94. PubMed ID: 5065568
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
    Salvioli GP; Allocca G; Ambrosioni G
    Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of various substrates on the spontaneous in vitro hemolysis of erythrocytes in hemolytic disease of the Rh and ABO newborn infant].
    Schettini F; Violante N; Mautone A
    Minerva Pediatr; 1969 Feb; 21(5):186-90. PubMed ID: 4975718
    [No Abstract]   [Full Text] [Related]  

  • 8. [The problem picture in the newborn with special reference to Rh and ABO factors].
    Spasova K; Matrova Ts
    Akush Ginekol (Sofiia); 1965; 4(5):486-7. PubMed ID: 4956859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn].
    Sirchia G; Ferrone S; Milani R; Masera G
    Haematol Lat; 1966; 9(3):215-20. PubMed ID: 4966138
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the kinetic characteristics of red blood cell acetylcholinesterase in ABO, Rh hemolytic disease of the newborn and thalassemia major cases.
    Ozand P; Artvinli S; Yarimağan S
    Turk J Pediatr; 1970; 12(1):1-7. PubMed ID: 4992911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythrocyte sedimentation and clinical findings in newborn infants with hemolytic disease].
    Maszkiewicz W; Irzyńska D
    Pediatr Pol; 1977 May; 52(5):503-6. PubMed ID: 407544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Frequency of the blood group substance Zd].
    Svanda M; Procházka R; Kout M
    Vnitr Lek; 1972 Sep; 18(9):838-41. PubMed ID: 4627757
    [No Abstract]   [Full Text] [Related]  

  • 13. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of a newborn infant with erythrocytes sensitized by anti-A 1 antibodies and absence of hematological and clinical findings of hemolytic disease].
    Scoppetta V
    Arch Ostet Ginecol; 1968; 73(3):391-6. PubMed ID: 4987886
    [No Abstract]   [Full Text] [Related]  

  • 15. [ABO system and RH-factor isoserological interrelations of the blood of the mother and child and their influences on erythrocyte kinetics in newborn infants].
    Dzhanibakhcheva VM; Kvezereli-Kopadze AN
    Akush Ginekol (Mosk); 1977 Oct; (10):36-40. PubMed ID: 415633
    [No Abstract]   [Full Text] [Related]  

  • 16. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
    Lindo-Haynes G
    Med Lab Sci; 1980 Jun; 37(3):263-6. PubMed ID: 6783806
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the prevention of Rh immunization in Sweden].
    Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA
    Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems of isoimmunization in the ABO system].
    Sauer J; Kulich V
    Cesk Gynekol; 1969 Oct; 34(8):483-5. PubMed ID: 4982152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reserve binding capacity of serum albumin for bilirubin in severe jaundice of the newborn infant].
    Rossipal E; Teubl I; Rosegger H
    Padiatr Padol; 1971 Jun; 6(2):205-12. PubMed ID: 5005469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.